ASEA Announces New Chief Science Officer to Lead Research and Development

USA - English

• USA - English

SALT LAKE CITY, Sept. 30, 2020 /PRNewswire-PRWeb/ -- ASEA, a global leader in cellular health, announced today the appointment of Nico Raczek, Ph.D., as chief scientific officer. Dr. Raczek will lead research and development and will oversee all redox scientific research and product development efforts.

Dr. Raczek will lead ASEA's global approach to the power of redox, bringing to his role as chief science officer decades of leadership in scientific strategies, new product development, research, and regulatory and scientific affairs. He has worked in Europe, the United States, Asia, and Africa, and has acquired global industry expertise in nutrition and health, cosmetics, and consumer goods as well as in the ingredients business and academia.

"We are thrilled to welcome Dr. Raczek to the ASEA executive team," said Jarom Webb, President of ASEA. Dr. Raczek will provide critical scientific vision for building a team of internal science professionals and leveraging outside independent expertise, focusing on the scientific foundation of our current redox signaling technology while developing and bringing to market new redox innovations

Known for his proactivity and his aptitude for thinking strategically, Dr. Raczek is also experienced in building teams across cultures and bringing clarity and direction to complex scientific, technical, and regulatory issues.

Dr. Raczek earned his Ph.D. in analytical chemistry and is a registered food chemist. He has supported the development of products for large corporations and holds 25 patents. Dr. Raczek is fluent in his native German, English, and French.

Press contact:
Kelly Kass
[email protected]

ASEA, a global leader in redox technology, is dedicated to delivering high-quality cellular health products through a principles-based, direct-selling business model. Harnessing science, ASEA offers first-to-market products that utilize molecules natural to the human body that support cellular functions. ASEA's cornerstone, patented redox signaling technology boosts the body's natural cellular renewal and communication as well as signals the activation of genetic pathways, supporting total body health and functions. Currently, redox signaling technology is available in three first-to-market products: ASEA® REDOX Cell Signaling Supplement, the company's flagship liquid supplement; RENU28® Revitalizing Redox Gel, an age-fighting, cellular-rejuvenating gel for the entire body; and RENUAdvanced™ Intensive Redox Serum, an ultra-concentrated, anti-aging skin therapy. ASEA offers other cellular health products that round out the RENUAdvanced skin care system as well as nutritional supplements. Founded in 2010, ASEA currently operates in upwards of 33 international markets. For more information about ASEA products or the accompanying business opportunity, visit ASEA Cellular Health.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE ASEA, LLC